MICHAEL BENKOWITZ - 06 May 2024 Form 4 Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Role: PRESIDENT AND COO
Signature: /s/ John S. Hess, Jr. under Power of Attorney
Issuer symbol: UTHR
Transactions as of: 06 May 2024
Net transactions value: -$3,130,162
Form type: 4
Filing time: 07 May 2024, 16:30:38 UTC
Previous filing: 03 Jan 2023
Next filing: 08 Aug 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	UTHR	Common Stock	Options Exercise	$5,258,260	+32,200	+1250%	$163.30	34,777	06 May 2024	Direct	F1, F2
transaction	UTHR	Common Stock	Disposed to Issuer	$8,388,422	-32,200	-93%	$260.51	2,577	06 May 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	UTHR	Share Tracking Award	Options Exercise	$0	-32,200	-100%	$0.000000^*	0	06 May 2024	Common Stock	32,200	$163.30	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This is an exercise of share tracking awards. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.
F2	Includes 118, 113, and 111 shares of common stock acquired on March 4, 2022, March 3, 2023, March 4, 2024, respectively, under the United Therapeutics Corporation Employee Stock Purchase Plan.